Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

341 results about "Tosyl" patented technology

A toluenesulfonyl (shortened tosyl, abbreviated Ts or Tos) group is CH₃C₆H₄SO₂. This group is usually derived from the compound tosyl chloride, CH₃C₆H₄SO₂Cl (abbreviated TsCl), which forms esters and amides of toluenesulfonic acid. The para orientation illustrated (p-toluenesulfonyl) is most common, and by convention tosyl refers to the p-toluenesulfonyl group.

Preparation method for tenofovir

The invention discloses a preparation method for tenofovir disoproxil fumarate, which comprises the following steps of: A, performing condensation reaction adenine and (R)-propylene carbonate which serve as raw materials to generate (R)-9-(2-hydroxypropyl) adenine; B, performing condensation reaction on the (R)-9-(2-hydroxypropyl) adenine and p-methylphenyl mesyloxy diethyl phosphonate under the catalysis of potassium alcoholate to prepare (R)-9-[2-(diethyl phosphonyl methoxy) propyl] adenine; C, reacting the (R)-9-[2-(diethyl phosphonyl methoxy) propyl] adenine obtained by the step B with para-toluenesulfonate acyl chloride to protect an amino group at bit four to prepare (R)-4-(p-toluenesulfonyl)-9-[2-(diethyl phosphonyl methoxy) propyl] adenine; D, hydrolyzing the (R)-4-(p-toluenesulfonyl)-9-[2-(diethyl phosphonyl methoxy) propyl] adenine obtained by the step C under a strong acid condition to obtain (R)-4-(p-toluenesulfonyl)-9-[2-(dihydroxy phosphonyl methoxy) propyl] adenine; and E, reacting the (R)-4-(p-toluenesulfonyl)-9-[2-(dihydroxy phosphonyl methoxy) propyl] adenine obtained by the step D with mercapto-benzene under a weak alkaline condition to remove a para-toluenesulfonate group to obtain the tenofovir. The invention aims to provide the preparation method for the tenofovir, which is low in cost, safe in process and good in product quality, and is suitable for industrialization.
Owner:ZHONGSHAN BAILING BIOTECHNOLOGY CO LTD

Tridentate nitrogen phosphine ligand and complex and application thereof in asymmetric catalytic hydrogenation of ketone

The invention belongs to the field of organic and medicine synthetic chemistry, and discloses a tridentate nitrogen phosphine ligand. The tridentate nitrogen phosphine ligand has a structure shown ina formula I which is shown in the attached figure, wherein R1 is toluene sulfonyl or 2,4,6-triisopropylbenzenesulfonyl, and R2 is aryl or substituted aryl. The invention also discloses a complex of the tridentate nitrogen phosphine ligand; the complex is prepared by mixing the tridentate nitrogen phosphine ligand and a transition metal complex; the complex is used for asymmetric catalytic hydrogenation of ketone. The tridentate nitrogen phosphine ligand has the advantages that 1, the synthesizing is easy, and the chiral ligand can be prepared by only two to three reaction steps; 2, the ligandis stable, the series of ligand is not sensitive to water and oxygen, and the convenience in storage and use is realized; 3, the catalyzing effect is good, and the catalyst can be used for realizing 100% of conversion and 99% of stereo selectivity on most of suitable primers; 4, the atom economy is high, and the activity of the catalysis system is higher; for most of suitable primers, the conversion number reaches more than 10000, and the maximum conversion number reaches 200000.
Owner:SHENZHEN CATALYS SCI & TECH CO LTD

Radioactive molecular probe taking TSPO as target point as well as preparation method and application thereof

The invention discloses a small molecular organic compound with a specific targeting TSPO (Transfer Protein). The structure of the small molecular organic compound comprises a benzene ring, pyrazolo imidazole and a diethyl acetamide structure. The P-toluenesulfonyl on a side chain of a benzene ring is used as a marker site; carrier-free radioactive fluorine-18 is used as a radioactive source; andmild alkaline reaction conditions are designed and utilized. By using a functional GE TRACERlab FX2N synthesizer, a target compound [18F] DPA714 is obtained through a one-step reaction. The method hasthe advantages of mild reaction conditions, simple steps, and automatic labeling; the non-attenuation correction yield reaches 40% or above; the radiochemical purity of the product is higher than 99%, the specific activity is higher than 148GBq / [mu] mol (4Ci / [mu] mol). The invention solves the technical problems of low labeling yield, low specific activity, complex operation and the like in the prior art. A radioactivity molecular probe prepared from the small molecular compound is shown as an imaging evaluation result of a positron emission tomography (PET) in patients (including Alzheimer'sdisease and cerebral apoplexy) with neuroinflammation related diseases, and the radioactivity molecular probe has the characteristics of high sensitivity, high sensitivity, high sensitivity, high sensitivity, high sensitivity, high sensitivity and the like. It is proved that the molecular probe has good specificity, targeting, stability and non-target tissue clearance rate.
Owner:THE FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIV

Cyclopropane alpha-amino acid derivatives containing continuous quaternary carbon center and synthesis method thereof

The invention belongs to the technical field of chemical synthesis of drugs, and discloses cyclopropane alpha-amino acid derivatives containing continuous quaternary carbon center and a synthesis method thereof. The synthesis method comprises the following steps: adding N-p-tolylsulfonylone hydrazone, methyl 2-acetaminoacrylate, an alkali, a phase-transfer catalyst and a solvent into a reactor, and stirring at 70-90 DEG C to react for 12-24 hours; and after the reaction finishes, cooling to room temperature, filtering the reaction solution, distilling under reduced pressure to remove the solvent to obtain a crude product, and purifying by column chromatography to obtain the cyclopropane alpha-amino acid derivatives containing continuous quaternary carbon center. The method avoids using any transition metal catalyst, and uses the nontoxic, cheap and accessible raw materials. The method has the advantages of high reaction adaptability to functional groups, wide substrate adaptability, high product yield and favorable diastereoselectivity, can implement gram-scale production and synthesis, and is beneficial to industrial production. The obtained product has wide application range in synthesis of pesticides, drugs and natural products.
Owner:SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products